Factors influencing postoperative hospitalization period after thoracoscopic surgery for acute empyema

Eiji Miyahara(Hiroshima University), Tsuneo Okumichi(Kajima Corporation (Japan)), A. Kimura(Hiroshima University), Yukari Kawasaki(Hiroshima General Hospital)

The Journal of the Japanese Association for Chest Surgery

January 1, 2018

10.2995/jacsurg.32.12

Cited by 2

Related Papers

Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26

|Clinical Infectious Diseases|2007|222

Valence band hybridization in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mrow><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:math>-rich<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">GaN</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="normal">As</mml:mi></mml:mrow><mml:mi>x</mml:mi></mml:msub></mml:mrow></mml:math>alloys

|Physical Review B|2004|94

High-quality InGaN MQW on low-dislocation-density GaN substrate grown by hydride vapor-phase epitaxy

|Journal of Crystal Growth|1998|82

Assessment of microchimerism in rat liver transplantation by polymerase chain reaction

|Hepatology|1996|43

Bevacizumab beyond disease progression after first‐line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non–small cell lung cancer (<scp>W</scp>est <scp>J</scp>apan <scp>O</scp>ncology <scp>G</scp>roup 5910L): An open‐label, randomized, phase 2 trial

|Cancer|2016|42